BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31410338)

  • 21. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Functional Organ Preservation by Concomitant Boost Radiotherapy Versus Concurrent Chemoradiation in Locally Advanced Carcinoma of Larynx or Hypopharynx: A Prospective Randomized Study.
    Hakim A; Ghoshal S; Verma R; Sharma SC
    Indian J Otolaryngol Head Neck Surg; 2019 Sep; 71(3):360-366. PubMed ID: 31559204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.
    Büntzel J; Glatzel M; Kuttner K; Weinaug R; Fröhlich D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):4-13. PubMed ID: 11917277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent chemo-irradiation using accelerated concomitant boost radiation therapy in loco-regionally advanced head and neck squamous cell carcinomas.
    Vivek RS; Baludavid M; Mohanram R; ; ; ; ; ;
    J Cancer Res Ther; 2006; 2(3):90-6. PubMed ID: 17998685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM).
    Fasanaro E; Del Bianco P; Groff E; Riva A; Petrangolini G; Busato F; Stritoni P; Scarzello G; Loreggian L; De Salvo GL
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L; Zhang YW; Hu CS; Guo Y
    Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
    Lee DJ; Cosmatos D; Marcial VA; Fu KK; Rotman M; Cooper JS; Ortiz HG; Beitler JJ; Abrams RA; Curran WJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):567-76. PubMed ID: 7790241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comparative Study on Weekly Versus Three Weekly Cisplatinum Based Chemoradiation in Locally Advanced Head and Neck Cancers.
    Sahoo TK; Samanta DR; Senapati SN; Parida K
    J Clin Diagn Res; 2017 Jan; 11(1):XC07-XC11. PubMed ID: 28274031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
    Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
    Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
    Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
    J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results.
    Adelstein DJ; Saxton JP; Lavertu P; Tuason L; Wood BG; Wanamaker JR; Eliachar I; Strome M; Van Kirk MA
    Head Neck; 1997 Oct; 19(7):567-75. PubMed ID: 9323144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Benefit of Placentrex in the Management of Acute Chemo Radiation Induced Mucositis in Oral Cancer Patients.
    Kondaveeti SS; C V D; John C; M M; S R
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3099-3103. PubMed ID: 30486548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical application of honey in the management of chemo/radiotherapy-induced oral mucositis: A systematic review and network meta-analysis.
    Yang C; Gong G; Jin E; Han X; Zhuo Y; Yang S; Song B; Zhang Y; Piao C
    Int J Nurs Stud; 2019 Jan; 89():80-87. PubMed ID: 30352321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
    Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of results by sequential and concurrent chemo radiotherapy in locally advanced carcinoma esophagus.
    Bhandari V; Gupta KL; Taran R
    Indian J Cancer; 2013; 50(4):341-4. PubMed ID: 24369214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
    Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.